Janus Henderson Capital Funds plc - Global Life Sciences Fund Class H2 Fonds
30,06
EUR
-0,62
EUR
-2,02
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 10,10% |
| UnitedHealth Group Inc | US91324P1021 | 5,98% |
| AstraZeneca PLC | GB0009895292 | 3,99% |
| Novo Nordisk A/S | DK0062498333 | 3,39% |
| Johnson & Johnson | US4781601046 | 3,30% |
| Abbott Laboratories | US0028241000 | 3,17% |
| Boston Scientific Corp | US1011371077 | 3,08% |
| Sanofi SA | FR0000120578 | 2,88% |
| Amgen Inc | US0311621009 | 2,76% |
| AbbVie Inc | US00287Y1091 | 2,74% |
| Sonstige | 58,61% |